Yamamoto N

No ORCID on file · 9 papers in corpus
2025
Serum miR-200c-3p and miR-6134 as diagnostic biomarkers for epithelial ovarian cancer.
Discover oncology ·doi:10.1007/s12672-025-03937-7

BackgroundMicroRNAs (miRNAs) regulate gene expression and are emerging as biomarkers for epithelial ovarian cancer (EOC). We evaluated the diagnostic performance of serum miR-200c-3p and miR-6134, alone and in combination with established m…

2024
Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers.
Journal for immunotherapy of cancer ·doi:10.1136/jitc-2024-009262

BackgroundImmunosuppressive conditions within the tumor microenvironment (TME) can allow tumors to evade the immune system, including by hampering programmed death ligand 1 (PD-L1) inhibitor activity. Interleukin (IL)-8 contributes to immun…

article 2022
Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study
Endocrine journal ·doi:10.1507/endocrj.ej22-0158

Dienogest (DNG) is widely used to treat dysmenorrhea associated with estrogen-dependent diseases such as endometriosis and adenomyosis. DNG becomes unnecessary after menopause when estrogen secretion declines drastically. However, there are…

article 2021
Ovarian reserve may influence the outcome of bone mineral density in patients with long-term use of dienogest
SAGE open medicine ·doi:10.1177/20503121211005992

Objective: Long-term administration of dienogest, which is known to have effect on bone mineral density, is frequently done in patients with endometriosis and adenomyosis, but a few studies focused on the bone mineral density changes after …

2021
Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations.
Translational oncology ·doi:10.1016/j.tranon.2021.101102

IntroductionMultiple primary lung cancers (MPLCs) occur in common carcinogenetic risks such as lifestyle, biological aging, immune responses, hormones, and metabolism. Although MPLCs harbor various genetic profiles within the same individua…

2020
Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for Hemoglobin.
Clinical and translational gastroenterology ·doi:10.14309/ctg.0000000000000176

IntroductionWe have reported previously that fecal DNA testing of TWIST1 methylation in combination with the fecal immunochemical test for hemoglobin (FIT) (combination test) is useful for colorectal neoplasia screening. In this study, usin…

article 2018
Long‐term dienogest administration in patients with symptomatic adenomyosis
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.13674

AIM: Adenomyosis is a common gynecological disorder that causes dysmenorrhea, hypermenorrhea and metrorrhagia. Previously, we reported that 24 weeks of dienogest treatment is highly effective for pain in symptomatic adenomyosis. Up to prese…

2013
Hysteroscopic adhesiolysis for patients with Asherman's syndrome: menstrual and fertility outcomes.
Reproductive medicine and biology ·doi:10.1007/s12522-013-0149-x

PurposeMost patients with Asherman's syndrome present with infertility and menstrual problems. In this retrospective clinical study, we analyzed patients with Asherman's syndrome who underwent hysteroscopic adhesiolysis to examine their ass…

1977
A diagnostic approach to inflammatory disease of the pancreas by means of endoscopic retrograde cholangio-pancreatography.
Gastroenterologia Japonica ·doi:10.1007/bf02774536

Role of ERCP in the diagnosis of inflammatory lesions of the pancreas was evaluated and following conclusions were obtained. 1) Following criteria were considered to be practical for clinical diagnosis of chronic pancreatitis by ERCP; a) Mo…